ADC Quality Assurance &
Potent Compound GMP Compliance

Build quality systems that support the biologic and potent small-molecule parts of
ADC manufacturing, testing, release, and lifecycle change.

Additional ADC QA Services

ADC Quality Assurance Ensuring Compliance & Product Integrity Across ADC Operations

ADC quality assurance needs to cover both biological GMP requirements and potent compound control. DES Pharma supports QA systems built for that combined risk profile, where product quality depends not only on antibody integrity and microbiological control, but also on controlled conjugation, containment, cleaning effectiveness, residual free payload limits, and disciplined change management.

We help sponsors build phase-appropriate QA systems for ADC manufacturing, testing, storage, and external oversight. That includes supplier qualification, occupational safety coordination, batch record review, deviation and CAPA management, inspection preparation, comparability governance, and batch release strategy. The goal is to align the quality system with real product risks, the analytical control approach, and the partner network from early clinical supply through commercial operations.

ADC QA System & Compliance Focus Areas

Where quality controls most often affect ADC execution and filing readiness

Our focus areas: potent compound GMP systems, cleaning validation, batch disposition logic, quality agreements, change control, and comparability oversight.

ADC-Focused QMS Design
Supplier Qualification & QA Agreements
Contained Manufacturing Oversight
Cleaning Validation & Carryover Risk
Deviation, CAPA & Change Control
Batch Release Strategy & Disposition
Lab QA & Data Integrity
Comparability & Post-Change Evaluation
Inspection Readiness & Response
APR, PQR & Lifecycle Quality Review

Quality Assurance Systems Smart, Efficient Operations
ADC QA System Coverage

Comprehensive quality assurance across every function that touches ADC product quality — from supplier qualification and deviation management through batch release and inspection readiness.

Supplier Management &
Qualification

Auditing & Assessment
Systems

Material Quality
Management

Manufacturing Operations QA

Technical Operations QA

QC Operations QA

Product Quality & Release

ADC Quality Priorities ADC Quality Priorities

A good ADC QA system defines what must be controlled because it affects patient safety, product consistency, operator protection, or filing support. For ADCs, those priorities usually extend beyond standard biologic GMP into potent compound handling, cleaning validation, conjugation-related comparability, and release decisions that bring together biologic and small-molecule quality data.

Potent Compound Containment & Exposure Control

Governance for PPE requirements, containment procedures, occupational exposure band compliance, and documented oversight for all personnel working with cytotoxic ADC payloads.

Batch Release Package Design

Integrated review of DAR distribution, potency, purity, residual free payload, and stability data, structured so the disposition decision is supported by complete and traceable records.

Cleaning Validation Strategy

Oversight for cleaning validation of shared or dedicated equipment with cytotoxic material risk, including worst-case product selection, swab method suitability, and carryover limit justification.

Stability Program Governance

Quality oversight for stability protocols monitoring linker integrity, payload retention, aggregate formation, and potency maintenance, with trending review and out-of-trend investigation procedures.

Comparability Assessment

Quality governance for process changes affecting DAR distribution, potency profile, or purity, including comparability protocol design, data review, and regulatory filing impact assessment. Pertained appropriately, and the batch record tells the full story.

Cross-Functional QA Oversight

Quality systems that span EHS, manufacturing, analytics, and supply chain, so containment controls, deviation investigations, change reviews, and supplier events are managed as one integrated risk picture.

ADC QA Expertise Quality Systems Built Around Real ADC Operations

ADC QA works best when it stays close to how the product is actually made and tested. DES Pharma helps sponsors build quality systems that reflect batch execution, analytical workflows, and outsourcing models rather than generic templates. We pay particular attention to the areas that can become inspection or release bottlenecks in ADC programs, including potent compound controls, cleaning and segregation logic, external partner oversight, batch record discipline, method lifecycle governance, and decision-making around changes and comparability.

 

Potent Compound Quality Systems

Contained operations, training records, and documented oversight for all cytotoxic material handling activities.

Cleaning & Segregation Planning

Carryover risk assessment, campaign management logic, and changeover expectations for ADC manufacturing equipment.

Batch Disposition Workflows

Review structures that support complete and timely disposition decisions for complex ADC release packages.

Partner Quality Governance

Oversight across manufacturers, testing labs, and logistics providers, with quality agreements matched to the risk profile of each relationship.

Inspection Preparation Inspection-Ready Before It Becomes Urgent

DES Pharma helps ADC sponsors prepare inspection-facing records, governance summaries, and quality narratives before the inspection window, so responses are prepared, not improvised.

Why DES Pharma for ADC QA Robust QA Processes Supporting
Reliable Outcomes

Quality systems designed for how ADC programs actually operate — not adapted from general biologics templates.

Practical Compliance

Quality systems designed to work in day-to-day manufacturing, testing, and partner management, not only to satisfy a checklist on paper or during an audit.

ADC-Focused Oversight

Quality thinking that reflects both the biologic and the potent small-molecule character of ADC products, across manufacturing, testing, storage, and distribution.

Cross-Functional Alignment

QA integrated across manufacturing, analytics, supply, and EHS, so deviation investigations, change reviews, and supplier events are managed with a complete risk picture.

Faster Issue Handling

Deviation, CAPA, and change control pathways designed to reach decisions more quickly, with appropriate documentation depth and cross-functional involvement built in from the start.

Release Confidence

Batch release structures supported by well-organized review packages, clear disposition criteria, and complete traceability, so release decisions are well-founded and defensible.

Lifecycle Durability

Quality systems built to remain functional through scale-up, PPQ, commercial launch, and post-approval change, not designed for one stage and then requiring reconstruction at the next.

Our ApproachADC QA Operating Model

A six-step framework for building quality systems that reflect real ADC operations, support timely decisions, and stay functional from clinical through commercial stage.

Clinical Supply Chain Consulting

Define Critical Quality Responsibilities

Map QA accountabilities across internal teams and external partners (including manufacturers, testing labs, payload suppliers, and logistics providers) to eliminate gaps in oversight.

Set Document & Data Review Pathways

Design batch record, analytical data, and documentation review workflows that support timely disposition decisions without creating bottlenecks or incomplete review trails.

Embed Risk Management

Apply ICH Q9-aligned risk assessment into supplier oversight, deviation investigation prioritization, CAPA planning, and change control evaluation for ADC-specific risk factors.

Connect Events to Product Quality

Link manufacturing deviations, analytical anomalies, and supply events back to product quality impact assessment, so QA decisions are grounded in patient safety, not just procedural compliance.

Prepare Inspection-Facing Records in Advance

Build governance summaries, batch genealogy narratives, and quality system documentation before inspection pressure, so health authority reviews are supported by organized, complete records.

Review Trends Proactively

Maintain regular management review, PQR, and APR cycles with ADC-relevant metrics so commercial quality oversight catches drift and recurrence patterns before they become deviation investigations.

Get Started Build ADC Quality Systems That Support Compliance, Release, and Day-to-Day Execution.

Connect with our QA team to discuss potent compound GMP systems, cleaning validation, batch release strategy, or inspection readiness for your ADC program.